anonymous
Guest
anonymous
Guest
I’ve been reading some pretty neat things about this company, it seems like I missed the last wave of expansion. Does anyone know if another wave is likely to happen this year, it seems like there’s a lot of room for growth with the label change that is apparently expected quite soon. I have gained a personal passion for cardiovascular medicine and I’m hoping to make the move to pharmaceutical sales (long term care now) in the upcoming year. Thanks!
Run! This company is a dud and the drug is a drug of last resort. Management is beyond incompetent and the CEO has a track record of failure. One thing Esperion does well is spend and burn money. Don't be an idiot. Once you have Esperion on your resume it will be a stain. Recruiters avoid this company and the quality of reps working at Esperion is very weak.